• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Biotech Market
Biotech News
Biotech Stocks
  • Biotech Market
  • Biotech News
  • Biotech Stocks

EnWave Announces First Quarterly Positive Net Income and Reports Consolidated Interim Financial Results for the Second Quarter Fiscal Year 2016

Matthew Spizziri
May. 26, 2016 01:03PM PST
Biotech Investing

EnWave Corporation (TSXV:ENW) (FRANKFURT: E4U) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2016. The Company reported consolidated revenue of $4,586,000, and a consolidated net income from continuing operations of $95,000 for the second quarter.As quoted in the press release: This quarter’s positive net income was a first …

EnWave Corporation (TSXV:ENW) (FRANKFURT: E4U) today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2016. The Company reported consolidated revenue of $4,586,000, and a consolidated net income from continuing operations of $95,000 for the second quarter.
As quoted in the press release:

This quarter’s positive net income was a first in the history of the Company. The material increase in revenues was due to the continued expansion and accelerated distribution of Moon Cheese® through EnWave’s subsidiary, NutraDried LLP, and the continued growth in sales of royalty-bearing Radiant Energy Vacuum (“REV™”) machines.
EnWave also generated positive cash flow from operating activities for the six months ended March 31, 2016, prior to changes to non-cash working capital, of $874,000.
Significant additional achievements in the second quarter include:

  • Receiving a purchase order for a 100kW REV™ machine from Gay Lea Foods Co-operative;
  • Signing a royalty-bearing Commercial License Agreement with Eregli Agrosan and receiving a purchase order for REV™ machinery;
  • Making significant milestones in design and construction of REV™ machines for two pharmaceutical partners; and,
  • Signing a Technology Evaluation and License Option Agreement with a major Australasian Dairy Company.

EnWave’s Radiant Energy Vacuum (“REV™”) technology is well positioned to capture market share in both the food and pharmaceutical drying industries. The intrinsic value of using REV™ technology as an alternative to conventional options has been proven in several market verticals on a global basis. EnWave anticipates continued commercial success and growth in the worldwide deployment of REV™ technology.

financial-results
The Conversation (0)

Go Deeper

AI Powered
Tech Outlook: Australia Edition

Tech Outlook: Australia Edition

Cronos Group Reports 2024 First Quarter Results

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Biotech Investing Stocks

More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES